Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Not for human consumption or pharmaceutical application
Legal Status / FDA Liraglutide is FDA-approved and legally available by prescription in the United States under two brand names: Victoza (approved January 2010): Type 2 diabetes in adults and children aged 10+, dosed at 1.2 to 1.8 mg daily Saxenda (approved December 2014): Chronic weight management in adults with BMI of 30 or greater (or 27+ with a weight-related comorbidity) and adolescents aged 12+ with obesity, dosed at 3.0 mg daily Liraglutide is not a controlled substance and is classified as a prescription medication in all major markets
The antithrombotic properties are consistent across different agents, suggesting a class effect rather than agent-specific differences [94]
Patients who should not use these medications include those with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, severe gastroparesis, or active eating disorders
US$ 27.57
US$ 28.89
US$ 20.09
US$ 23.45
US$ 28.58
US$ 23.22
.png)
